RxSight
RXST
40 hedge funds and large institutions have $75M invested in RxSight in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 4 closing their positions.
171% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 7
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
3% more funds holding
Funds holding: 39 → 40 (+1)
4.63% less ownership
Funds ownership: 29% → 24.37% (-4.6%)
25% less capital invested
Capital invested by funds: $100M → $75M (-$25.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sessa Capital
New York
|
+$1.97M |
| 2 |
O
OrbiMed
New York
|
+$1.6M |
| 3 |
BlackRock
New York
|
+$550K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$525K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$498K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$11.4M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.46M |
| 3 |
Millennium Management
New York
|
-$1.31M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$1.27M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$839K |
RXST Hedge Fund Activity: Q4 2021 in Review
40 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2021, worth a combined $75M — down 25% from $100M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RXST positions and 4 closed out — a net gain of 2 holders — while 19 added to existing stakes and 7 trimmed.
The largest buyer was Sessa Capital, opening a new position worth an estimated $1.97M. The largest seller was Deerfield Management, exiting entirely with an estimated $11.4M sold.
- 40 institutional investors held RxSight (RXST) as of Q4 2021, up from 39 in Q3 2021.
- Funds reported $75M of RxSight stock for Q4 2021, down 25% quarter-over-quarter.
- 6 funds opened new RxSight positions in Q4 2021 and 4 closed out, a net change of +2 holders.
- The largest RxSight buyer in Q4 2021 was Sessa Capital, an estimated $1.97M added.
- The largest RxSight seller in Q4 2021 was Deerfield Management, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2021.